Metoprolol Tartrate Injection, Solution
Product Images NDC 51662-1478

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metoprolol Tartrate (NDC 51662-1478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse (Adverse Reactions 1)

This text provides a comparison between the effects of Metoprolol Tartrate and placebo on different medical conditions, including hypotension, bradycardia, heart block, and heart failure. It shows percentages of patients who experienced these conditions while taking either Metoprolol Tartrate or a placebo.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

How Supplied (How Supplied)

The text describes a unit of sale available in two NDC codes, one for a single dose glass fliptop vial containing 5mg/5mL and the other for a carton of 10. The concentration is also mentioned as 1mg/ml.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Labeling)

This text is describing a medication called Metoprolol Tart, which is an injection drug for intravenous use. It is available in a 5mL single-dose vial that is for RX only. The manufacturer is HF Acquisition Co., LLC and it is distributed by Hospira, Inc. The packaging insert should be consulted before use. The drug must be protected from light. Other numbers and codes are also included in the text.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label Option 1 (Vial Label Option 1)

This is a description of a medication in a single-dose vial format with the name Metoprolol Tartrate. It is an injection that has a strength of 5mg/5mL and is intended for intravenous use. It has an NDC code of 0409-1778-15 and is available only with a prescription. The medication must be protected from light and is distributed by Hospira Inc. in Lake Forest, IL, USA.*

FDA Label Image

Vial Label Option 2 (Vial Label Option 2)

FDA Label Image

Vial Label Option 3 (Vial Label Option 3)

FDA Label Image

Warning (Warnings)

This text provides important information on the use of metoprolol tartrate in patients with coronary artery disease. It warns against abruptly discontinuing therapy as it can lead to severe exacerbation of angina, myocardial infarction and ventricular arrhythmias. In case of discontinuation, the patient should be carefully monitored and the dosage should be gradually reduced over a period of 10-2 weeks. Patients should not interrupt or discontinue therapy without the physician's advice. Even in patients treated only for hypertension, it may be prudent not to discontinue metoprolol tartrate therapy abruptly as coronary artery disease is common and may be unrecognized.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.